Albustix Urine Protein Test Strips, 50-Piece
About this deal
Flucloxacillin is indicated for the treatment of infections due to penicillinase producing staphylococci and other gram positive organisms susceptible to this anti-infective (see Section 5.1). The specifications and figures contained in our catalogues are provided as indications only, and are not of a contractual character. VWR reserves the right to change its articles without advance notice according to improvements which might be required by progress in the applicable technologies. Stone, R. C. et al. Interferon regulatory factor 5 activation in monocytes of systemic lupus erythematosus patients is triggered by circulating autoantigens independent of type I interferons. Arthritis Rheum. 64, 788–798 (2012).
Albustix Reagent Strips for Urinalysis, Tests for Protein Albustix Reagent Strips for Urinalysis, Tests for Protein
Touma, Z. & Gladman, D. D. Current and future therapies for SLE: obstacles and recommendations for the development of novel treatments. Lupus Sci. Med. 4, e000239 (2017).
Full size image IRF5 regulates oxidative phosphorylation (OXPHOS) in a Lyn-deficient mouse SLE model A reporter system that distinguishes the transcriptional activities of IRF5 and NF-κB was established and used for HTS. A library containing ~100,000 compounds was subjected to the screening via the reporter system to identify the compounds that selectively inhibit IRF5 transcriptional activity, thereby yielding 26 small-molecule hit compounds. Ten of these hit compounds were validated by endogenous gene expression analysis. One of the validated hit compounds strongly inhibited IRF5 activation at a dose much different from its toxic dose. After that, several analogs of the confirmed hit compound were assessed. One of these compounds, YE6144, was found to have better photoisomerization properties and less toxicity in vivo. Statistical analysis New materials and equipment sold by VWR are covered, unless otherwise stated, against any manufacturing defects for a period of 12 to 24 months from:
The STIX Family - Siemens Healthineers
Takaoka, A. et al. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 434, 243–249 (2005). VWR has a range of new services designed to streamline your operations, help you make cost savings and manage your laboratory effectively...Advertise or offer to sell or buy any goods or services for any business purpose, unless such Community Feature specifically allows such messages. Morand, E. F. et al. Trial of anifrolumab in active systemic lupus erythematosus. N. Engl. J. Med. 382, 211–221 (2020). VWR is ready to support your production facility with reliable access to raw materials and essential supplies. We can also help you increase productivity...
Albustix® | VWR Urine test strips, Albustix® | VWR
Science education supplies, specimens, activities, and equipment for all grade levels – kindergarten to collegeWe expected that our IRF5 inhibitor would suppress the progression of mouse SLE, similar to the results obtained following the Irf5 conditional deletion in Lyn-deficient mice. Indeed, the administration of YE6144 suppressed the exacerbation of autoantibody production in NZB/W F1 mice, another mouse SLE model, both before and after disease onset (Supplementary Fig. 11a–d). Splenomegaly and renal dysfunction were also suppressed by YE6144 treatment after disease onset (Supplementary Fig. 11e–h). Unexpectedly, increases in CD80 on cDC2s, CD69 on CD4 + T cells, and the TMRM signals in Ly6C − monocytes and pDCs in dimethyl sulfoxide (DMSO)-treated NZB/W F1 mice were not evident compared to WT C57BL/6 mice and YE6144-treated NZB/W F1 mice (Supplementary Fig. 11i–k). We infer that the mechanism of the disease in NZB/W F1 mice may be somewhat distinct from the Lyn-deficient mouse model and human SLE. Morino, K. et al. Antibody fusions with fluorescent proteins: a versatile reagent for profiling protein expression. J. Immunol. Methods 257, 175–184 (2001). T.B., M.K., and T. Tamura designed the study; T.B., M.K., G.R.S., A.M., N.T., K.H., Y.M., and S.S. conducted the experiments; T.B., M.K., G.R.S., A.M., N.T., K.H., A.N., K.N., R.Y., Y.K., H.Y., Y.M., S.S., H.H., M.I., K.T., K.Y., T.Y., T. Taniguchi, H.N., S.I., and T. Tamura analyzed the data; T.B., M.K., and T. Tamura wrote the manuscript; K.N., R.Y., Y.K., H.Y., Y.M., S.S., H.H., K.T., K.Y., T.Y., T. Taniguchi, H.N., and S.I. provided key materials; K.N., R.Y., Y.K., H.Y., Y.M., S.S., H.H., K.T., K.Y., T.Y., T. Taniguchi, H.N., and S.I. provided critical suggestions for the study; and T. Tamura supervised the project. Corresponding authors